Eyebright Medical Receives NMPA Class III Certificate for its Phakic Intraocular Lens
Co., Ltd. ("Eyebright Medical", the "Company", Stock Code: 688050.SH, together with its subsidiaries collectively known as ...
PharmiWeb8d
Global Intraocular Lens Market Set to Reach USD 8.2 Billion by 2032, Driven by Increasing Demand for Multifocal Lenses | FMI
The global intraocular lens market is experiencing significant growth, with 2022 sales projected to reach USD 4.6 billion, according to a newly released analysis from Future Market Insights. The ...
Light-adjustable lenses give power to personalize after cataracts surgery
The light-adjustable lens is the world’s first customizable intraocular lens after cataract surgery. Hartford HealthCare is ...
Impacts10d
Reclaim Your Sight: Safe and Effective Cataract Solutions
Introduction Cataracts are an all too familiar ailment that affects millions, usually distorting vision and reducing people’s ...
Staar Surgical: Hold Rating Amid Competitive Pressures and Strategic Initiatives
Canaccord Genuity analyst John Young CFA has maintained their neutral stance on STAA stock, giving a Hold rating yesterday.Stay Ahead of the ...
Carl Zeiss Meditec (0DHC) Receives a Hold from UBS
In a report released today, Graham Doyle from UBS maintained a Hold rating on Carl Zeiss Meditec (0DHC – Research Report), with a price target ...
Eyebright Medical Technology (Beijing) Co., Ltd.: Eyebright Medical Receives NMPA Class III Certificate for its Phakic Intraocular Lens
Co., Ltd. ("Eyebright Medical", the "Company", Stock Code: 688050.SH, together with its subsidiaries collectively ...